Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucio Cocco

Showing results (211-220 of 238) with videos related to

Pageof 24
Sort By:
Journal of Cellular Physiology|February 9, 2011
Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathwaysJames A McCubrey, Linda S Steelman, C Ruth Kempf, et al.
Advances in Biological Regulation|July 8, 2018
Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticalsStephen L Abrams, Kvin Lertpiriyapong, Li V Yang, et al.
Advances in Biological Regulation|December 8, 2024
Signaling pathways and bone marrow microenvironment in myelodysplastic neoplasmsEleonora Ceneri, Alessia De Stefano, Irene Casalin, et al.
Clinical Epigenetics|February 21, 2023
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromesSara Mongiorgi, Alessia De Stefano, Stefano Ratti, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 4, 2019
Phospholipase C-β1 potentiates glucose-stimulated insulin secretionHyeon-Jeong Hwang, Yong Ryoul Yang, Hye Yun Kim, et al.
Advances in Biological Regulation|January 19, 2024
Deciphering signaling pathways in hematopoietic stem cells: the molecular complexity of Myelodysplastic Syndromes (MDS) and leukemic progressionIrene Casalin, Alessia De Stefano, Eleonora Ceneri, et al.
Cells|April 30, 2021
GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and NutraceuticalsStephen L Abrams, Shaw M Akula, Akshaya K Meher, et al.
Advances in Biological Regulation|February 28, 2018
Metformin influences drug sensitivity in pancreatic cancer cellsSaverio Candido, Stephen L Abrams, Linda Steelman, et al.
Advances in Biological Regulation|August 11, 2020
Cancer therapy and treatments during COVID-19 eraShaw M Akula, Stephen L Abrams, Linda S Steelman, et al.
Advances in Biological Regulation|October 27, 2018
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cellsStephen L Abrams, Matilde Y Follo, Linda S Steelman, et al.
Pageof 24

Showing results (211-220 of 238) with videos related to

Sort By:
Pageof 24
Journal of Cellular Physiology|February 9, 2011
Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathwaysJames A McCubrey, Linda S Steelman, C Ruth Kempf, et al.
Advances in Biological Regulation|July 8, 2018
Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticalsStephen L Abrams, Kvin Lertpiriyapong, Li V Yang, et al.
Advances in Biological Regulation|December 8, 2024
Signaling pathways and bone marrow microenvironment in myelodysplastic neoplasmsEleonora Ceneri, Alessia De Stefano, Irene Casalin, et al.
Clinical Epigenetics|February 21, 2023
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromesSara Mongiorgi, Alessia De Stefano, Stefano Ratti, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 4, 2019
Phospholipase C-β1 potentiates glucose-stimulated insulin secretionHyeon-Jeong Hwang, Yong Ryoul Yang, Hye Yun Kim, et al.
Advances in Biological Regulation|January 19, 2024
Deciphering signaling pathways in hematopoietic stem cells: the molecular complexity of Myelodysplastic Syndromes (MDS) and leukemic progressionIrene Casalin, Alessia De Stefano, Eleonora Ceneri, et al.
Cells|April 30, 2021
GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and NutraceuticalsStephen L Abrams, Shaw M Akula, Akshaya K Meher, et al.
Advances in Biological Regulation|February 28, 2018
Metformin influences drug sensitivity in pancreatic cancer cellsSaverio Candido, Stephen L Abrams, Linda Steelman, et al.
Advances in Biological Regulation|August 11, 2020
Cancer therapy and treatments during COVID-19 eraShaw M Akula, Stephen L Abrams, Linda S Steelman, et al.
Advances in Biological Regulation|October 27, 2018
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cellsStephen L Abrams, Matilde Y Follo, Linda S Steelman, et al.
Pageof 24